Overview

TCR-T Cells in the Treatment of Advanced Pancreatic Cancer

Status:
Recruiting
Trial end date:
2024-09-07
Target enrollment:
Participant gender:
Summary
To investigate the safety, tolerability, efficacy and pharmacokinetics of TCR-T cells in the treatment of advanced pancreatic cancer
Phase:
Early Phase 1
Details
Lead Sponsor:
Ruijin Hospital
Collaborator:
Shanghai Essight Bio Co.,Ltd